Bovilis Piliguard Pinkeye+7

Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C & D-Moraxella Bovis Bacterin-Toxoid

This product has been shown effective for the vaccination of healthy cattle against pinkeye due to Moraxella bovis and diseases due to Clostridium chauvoei, C. septicum, C. novyi Type B, C. sordellii and C. perfringens Types C and D. This product was licensed prior to the requirement to establish a minimum age for use. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

DOSAGE: Shake well and administer a single 5.0 mL dose aseptically by the subcutaneous route. Repeat the dose in 3 - 4 weeks. For advice on revaccination frequency, contact your veterinarian.

Bovilis Piliguard Pinkeye+7 Caution

Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not mix with other products. Do not vaccinate within 21 days before slaughter. This product has not been tested in pregnant animals. Transient local reactions may occur at the injection site. If allergic reaction occurs, treat with epinephrine. In case of human exposure, contact a physician. Contains gentamicin, formaldehyde and thimerosal as preservatives.

FOR ANIMAL USE ONLY

Intervet Inc., d/b/a Merck Animal Health, Omaha, NE 68103 USA

VLN 165A/PCN 7425.02

1 800 521-5767

For patent information: http://www.merck.com/product/patent/home.html

CPN: 1047578.0